SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to transform patient care by ...

SOPHiA GENETICS SA is a healthcare technology company ... It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex ...

SOPHiA GENETICS. "Following the successful launch of MSK-ACCESS ® powered with SOPHiA DDM™ earlier this year, we are incredibly excited to further build on our excellent collaboration with MSK.

In a report released on February 4, Conor McNamara from RBC Capital maintained a Buy rating on SOPHiA GENETICS (SOPH – Research Report), with a ...

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, announced the global launch of MSK-IMPACT® powered with SOPHiA DDM™ today from the ...

This innovation underscores SOPHiA GENETICS' commitment to advancing data ... The OncoPortal™ Mutation Tracker augments the SOPHiA DDM™ Platform's core analytical capabilities to allow ...

SOPHiA GENETICS (Nasdaq: SOPH ... It is the creator of the SOPHiA DDM™ Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad ...

This innovation underscores SOPHiA GENETICS' commitment to advancing data-driven approaches ... The OncoPortal™ Mutation Tracker augments the SOPHiA DDM™ Platform's core analytical capabilities to ...